CM
BSX icon

Capula Management’s Boston Scientific BSX Stock Holding History

Capula Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,500
Closed -$334K – 1089
2025
Q4 		$334K Sell
3,500
-2,500
-42% -$245K ﹤0.01% 466
2025
Q3 		$586K Buy
6,000
+4,400
+275% +$456K ﹤0.01% 427
2025
Q2 		$172K Buy
1,600
+200
+14% +$20.2K ﹤0.01% 400
2025
Q1 		$141K Buy
+1,400
New +$141K ﹤0.01% 582
2023
Q2 		– Sell
-136,800
Closed -$6.84M – 464
2023
Q1 		$6.84M Sell
136,800
-3,200
-2% -$151K 0.08% 197
2022
Q4 		$6.48M Buy
+140,000
New +$6.06M 0.09% 225
2020
Q1 		– Sell
-6,400
Closed -$289K – 365
2019
Q4 		$289K Sell
6,400
-45,700
-88% -$1.91M 0.01% 336
2019
Q3 		$2.12M Buy
+52,100
New +$2.21M 0.05% 230

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capula Management's BSX Position: Q1 2026 in Review

Capula Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 967 shares — an estimated $92.2K sold.

Capula Management first reported a position in BSX in Q3 2019 and held it in 8 quarters. The position peaked at $821K in Q3 2019. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Capula Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Capula Management sold 967 Boston Scientific shares in Q1 2026, an estimated $92.2K.
  • Capula Management first reported a position in Boston Scientific in Q3 2019 and held it in 8 quarters.
  • Capula Management's Boston Scientific position peaked at $821K in Q3 2019.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.